| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Fluoride toothpaste |
| Brand | Duraphat® 5,000 ppm |
| Indication | For the prevention of dental caries in adolescents and adults, particularly amongst patients at risk from multiple caries (coronal and/or root caries). |
| Assessment Process | |
| Rapid review commissioned | 30/07/2019 |
| Rapid review completed | 06/01/2020 |
*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods Act) 2013.